Repurposing of Cetuximab in antibody-directed chemotherapy-loaded nanoparticles in EGFR therapy-resistant pancreatic tumours
2019 · Nanoscale · 53 citations
https://doi.org/10.1039/c9nr07257h
M
Michelle K. Greene
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
68
Papers
739
Citations
14
h-index
16
i10-index
Michelle K. Greene is an academic researcher from Queen's University Belfast. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Cancer Genomics and Diagnostics & Cancer Research and Treatments. The author has an h-index of 14, co-authored 58 publications.
ORCID: 0000-0003-2318-9320Papers by this author
worksOptimising intracellular delivery of antibiotic loaded PLGA nanoparticles to macrophages
2024 · International Journal of Pharmaceutics · 7 citations
https://doi.org/10.1016/j.ijpharm.2024.124567
Analysis of SARS-CoV-2 antibody seroprevalence in Northern Ireland during 2020–2021
2024 · Heliyon · 1 citations
https://doi.org/10.1016/j.heliyon.2024.e24184
Supplementary Figure S3 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors
2024 · 0 citations
https://doi.org/10.1158/1078-0432.25515943
Data from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors
2024 · 0 citations
https://doi.org/10.1158/1078-0432.c.7158244.v1
Supplementary Table S2 from Dual-Hit Strategy for Therapeutic Targeting of Pancreatic Cancer in Patient-Derived Xenograft Tumors
2024 · 0 citations
https://doi.org/10.1158/1078-0432.25515916.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat